NTON 24001 Scope and Field of Application

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Chapter 2, CAMPO DE APLICACIÓN, of NTON 24001:2023 confines the scope to five categories of actors: natural or legal persons who manufacture (fabrican), refurbish or upgrade (repotencian), reprocess (reprocesan), re-sterilise (reesterilizan) or import (importan) medical devices for distribution and commercialisation. Chapter 1, OBJETO, confines the purpose to the sanitary registration of devices for human use. GRZAN regulatory team note: the verbs of the scope clause are an exhaustive list; purely local distribution, pure retail and in-house use by healthcare institutions are not within the letter of Chapter 2. However, Chapter 5 Articles 1 and 6 pull the circulation end back into the chain of obligations through two provisions: importers or distributors must comply, and operating a business requires a licence.

2. Legal basis

The table below maps the scope provisions of the standard and the resolution, together with the definitions that give refurbished, second-hand and controlled-technology equipment their boundaries.

Mandatory technical standardNTON 24001:2023Chapter 1 (OBJETO)This standard establishes the requirements and provisions for the granting of sanitary registration of medical devices for human use
Mandatory technical standardNTON 24001:2023Chapter 2 (CAMPO DE APLICACIÓN)Applies to natural or legal persons who manufacture, refurbish, reprocess, re-sterilise or import devices for distribution and commercialisation
Mandatory technical standardNTON 24001:2023Chapter 5 Article 1Importers or distributors must complete registration under this standard according to risk class, before the product enters the country for commercialisation and distribution
Mandatory technical standardNTON 24001:2023Chapter 5 Article 6Establishments engaged in manufacture, import or distribution must hold a valid sanitary licence issued by the competent authority and may only perform the activities the licence authorises
Administrative resolutionRA 0007/2025Annex I Articles 1 and 2The licence covers manufacture, maintenance and repair, refurbishment, reprocessing, sterilisation or re-sterilisation, repackaging, import, distribution and commercialisation; it applies to such establishments and to users
DefinitionsNTON 24001:2023Definition items 20 and 21Definition of refurbished equipment (repotenciado) and second-hand equipment (usado); second-hand equipment must not exceed 5 years since manufacture or assembly
Mandatory technical standardNTON 24001:2023Definition item 10Controlled-technology devices: high risk class, prototypes, second-hand or refurbished equipment, Classes III and IV

3. Expert insights

Point 1: The five verbs of Chapter 2 are an exhaustive list, not examples. The original text reads fabrican, repotencian, reprocesan, reesterilizan o importan: manufacture, refurbish, reprocess, re-sterilise, import. These five actions cover every point of origin through which a product can enter the Nicaraguan market: made locally, refurbished locally, reprocessed locally, re-sterilised locally, or brought in from abroad.

Point 2: The scope of RA 0007/2025 is wider than Chapter 2 of the NTON. Article 1 of Annex I of the resolution addresses establishments engaged in manufacture, maintenance and repair, refurbishment, reprocessing, sterilisation or re-sterilisation, repackaging, import, distribution and commercialisation, and Article 2 goes further by capturing users (utilicen) as well. The reason is that the resolution governs the sanitary licence, an establishment qualification, while Chapter 2 of the NTON governs sanitary registration, a product qualification. The two lines have different scopes and cannot be applied to each other.

Point 3: Refurbished and second-hand equipment have dedicated statutory definitions and an age limit. Definition item 20 confines refurbished equipment to equipment whose main subsystems have been replaced with new parts by the manufacturer or a refurbisher authorised by the manufacturer, and which conforms to the manufacturer specifications and the original construction safety standards. Definition item 21 confines second-hand equipment to equipment used for no more than 5 years, counted from manufacture or assembly. Both are placed by definition item 10 into controlled-technology devices, alongside Class III and IV devices and prototypes.

Point 4: Distribution and commercialisation fall outside the verbs of Chapter 2 yet return through Chapter 5. Chapter 5 Article 1 requires the importer or distributor to complete registration by risk class before the goods enter the country; Chapter 5 Article 6 requires establishments engaged in manufacture, import or distribution to hold a valid sanitary licence. A distributor is therefore not a bystander: it is one of the bearers of the registration obligation and also a licence holder.

Point 5: Chapter 2 does not cover in-house use by healthcare institutions. The closing phrase of Chapter 2 is para su distribución y comercialización, for their distribution and commercialisation. Although Article 2 of RA 0007/2025 brings users within its own scope, that provision addresses sanitary licensing matters. Whether an entity falls within Chapter 2 of the NTON turns on whether its conduct is directed at distribution and commercialisation.

Point 6: The purpose clause confines the object to human use. Chapter 1 reads dispositivos médicos de uso humano, devices for human use, and Articles 1 and 3 of RA 0007/2025 likewise emphasise de uso humano repeatedly. Veterinary devices are outside this volume, and this point creates no exception when preparing labels and monographs.

4. Practical recommendations

  • Establish actor identity through the five verbs: first confirm whether the activity is manufacture, refurbishment, reprocessing, re-sterilisation or import, and only then determine the registration obligation and licence category. Do not pass over the question with the phrase we are a distributor.
  • File second-hand and refurbished equipment separately: verify subsystem replacement records, manufacturer authorisations and the 5-year limit against items 20 and 21, and prepare the dossier as controlled-technology devices under item 10.
  • Have distributors obtain the licence in parallel: Chapter 5 Article 6 requires distribution establishments to hold a valid sanitary licence and to perform only the licensed activities; changing the scope of business requires changing the licence first.
  • Run establishment qualification and product qualification as two separate applications: the sanitary licence goes through the establishment channel of RA 0007/2025 and the sanitary registration through the product channel of Chapter 6 of the NTON. Do not merge them into one application.
  • Map user-side obligations separately: healthcare institutions are users within Article 2 of RA 0007/2025, and their licensing and product registration obligations differ; this must be made clear in client training material.
  • Write the human-use limitation into internal templates: the product name and intended-use descriptions in all external documents should carry de uso humano uniformly, to prevent veterinary products from being handled with the same set of documents.

5. Verification checklist

  • □ The actor activity category has been confirmed against the five verbs of Chapter 2 and the determination record retained
  • □ The product has been confirmed to be a device for human use
  • □ For second-hand or refurbished equipment, replacement records and the 5-year limit have been verified against items 20 and 21
  • □ Controlled-technology devices have been captured under item 10 and the dossier prepared to Class III or IV standards
  • □ The distribution establishment holds a valid sanitary licence covering its business activities
  • □ Establishment licensing and product registration have been filed through separate channels and not merged
  • □ External documents uniformly carry the marking de uso humano

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications through the regulatory directorate, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail